CN114126599A - 改变衰老相关分泌表型的方法和组合物 - Google Patents

改变衰老相关分泌表型的方法和组合物 Download PDF

Info

Publication number
CN114126599A
CN114126599A CN202080052117.8A CN202080052117A CN114126599A CN 114126599 A CN114126599 A CN 114126599A CN 202080052117 A CN202080052117 A CN 202080052117A CN 114126599 A CN114126599 A CN 114126599A
Authority
CN
China
Prior art keywords
composition
akg
subject
vitamin
composition comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080052117.8A
Other languages
English (en)
Chinese (zh)
Inventor
B·肯尼迪
G·利思高
A·沙米尔扎迪
C·威利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Buck Institute for Research on Aging
Original Assignee
Buck Institute for Research on Aging
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buck Institute for Research on Aging filed Critical Buck Institute for Research on Aging
Publication of CN114126599A publication Critical patent/CN114126599A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN202080052117.8A 2019-06-10 2020-06-10 改变衰老相关分泌表型的方法和组合物 Pending CN114126599A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962859623P 2019-06-10 2019-06-10
US62/859,623 2019-06-10
PCT/US2020/036974 WO2020252005A1 (en) 2019-06-10 2020-06-10 Methods and compositions for altering senescence associated secretory phenotype

Publications (1)

Publication Number Publication Date
CN114126599A true CN114126599A (zh) 2022-03-01

Family

ID=73781254

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080052117.8A Pending CN114126599A (zh) 2019-06-10 2020-06-10 改变衰老相关分泌表型的方法和组合物

Country Status (7)

Country Link
US (1) US20220241229A1 (cg-RX-API-DMAC7.html)
EP (1) EP3980000A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022536653A (cg-RX-API-DMAC7.html)
CN (1) CN114126599A (cg-RX-API-DMAC7.html)
AU (1) AU2020293094A1 (cg-RX-API-DMAC7.html)
CA (1) CA3142781A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020252005A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115813784A (zh) * 2022-11-28 2023-03-21 麦吉丽生物科技有限公司 α-酮戊二酸、含有α-酮戊二酸的米发酵液在制备皮肤炎症抑制剂中的用途

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112955139B (zh) 2018-09-25 2025-04-18 庞塞迪利昂健康特定活动公司 用于制备α-酮戊二酸钙的方法
DE102021111719A1 (de) * 2021-05-05 2022-11-10 Henkel Ag & Co. Kgaa Erhalt der Haarstruktur gegenüber Umwelteinflüssen umfassend ein Phenol und multivalente Ionen
WO2023191106A1 (ja) * 2022-04-01 2023-10-05 公益財団法人がん研究会 老化細胞もしくはsaspを標的とした治療薬/予防薬、老化細胞を検出するデータの取得方法及び治療薬/予防薬のスクリーニング方法
EP4561696A4 (en) * 2022-06-30 2026-07-15 Mechanobiologics Inc REVERSAL OF CELLULAR SENENCE BY LOW-FREQUENCY ULTRASOUND TREATMENT
WO2024123738A1 (en) * 2022-12-06 2024-06-13 Ponce De Leon Health Designated Activity Company Compositions and methods for treating diseases responsive to akg-vitamin b coadministration

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
US20040072160A1 (en) * 2001-05-22 2004-04-15 Donna Mendrick Molecular toxicology modeling
US20090069429A1 (en) * 2006-04-21 2009-03-12 Sgp & Sons Ab Compositions Comprising Alpha-Ketoglutarate and Their Use for Modulating Muscle Performance
WO2012143405A1 (en) * 2011-04-18 2012-10-26 Nestec S.A. Nutritional compositions having alpha-hica and alpha-ketoglutarate
US20150328176A1 (en) * 2013-01-25 2015-11-19 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
CN106163557A (zh) * 2014-01-28 2016-11-23 巴克老龄化研究所 用于杀死衰老细胞和用于治疗衰老相关疾病和病症的方法和组合物
CN106963749A (zh) * 2017-03-23 2017-07-21 华南农业大学 α‑酮戊二酸(盐)在抗疲劳和提高肌肉运动力量方面的应用
WO2018200736A2 (en) * 2017-04-25 2018-11-01 The Buck Institute For Research On Aging Formulations for extending lifespan and healthspan
CN108774203A (zh) * 2018-06-25 2018-11-09 北京未蓝时代科技有限公司 一种延缓哺乳动物细胞和机体衰老的化合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2510690T3 (es) * 2004-12-17 2014-10-21 Alan B. Cash Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
US20070105942A1 (en) * 2005-11-08 2007-05-10 Heuer Marvin A Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways
US20110039935A1 (en) * 2007-07-02 2011-02-17 Entress Ab Use of pharmacologically active chemical compounds
DE102009016119A1 (de) * 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
CN113082009A (zh) * 2014-02-12 2021-07-09 加利福尼亚大学董事会 用于治疗衰老和与年龄相关的疾病和症状的组合物和方法
US20210369750A1 (en) * 2018-10-24 2021-12-02 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
US20040072160A1 (en) * 2001-05-22 2004-04-15 Donna Mendrick Molecular toxicology modeling
US20090069429A1 (en) * 2006-04-21 2009-03-12 Sgp & Sons Ab Compositions Comprising Alpha-Ketoglutarate and Their Use for Modulating Muscle Performance
WO2012143405A1 (en) * 2011-04-18 2012-10-26 Nestec S.A. Nutritional compositions having alpha-hica and alpha-ketoglutarate
US20150328176A1 (en) * 2013-01-25 2015-11-19 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
CN106163557A (zh) * 2014-01-28 2016-11-23 巴克老龄化研究所 用于杀死衰老细胞和用于治疗衰老相关疾病和病症的方法和组合物
CN106963749A (zh) * 2017-03-23 2017-07-21 华南农业大学 α‑酮戊二酸(盐)在抗疲劳和提高肌肉运动力量方面的应用
WO2018200736A2 (en) * 2017-04-25 2018-11-01 The Buck Institute For Research On Aging Formulations for extending lifespan and healthspan
CN108774203A (zh) * 2018-06-25 2018-11-09 北京未蓝时代科技有限公司 一种延缓哺乳动物细胞和机体衰老的化合物及其应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115813784A (zh) * 2022-11-28 2023-03-21 麦吉丽生物科技有限公司 α-酮戊二酸、含有α-酮戊二酸的米发酵液在制备皮肤炎症抑制剂中的用途

Also Published As

Publication number Publication date
AU2020293094A1 (en) 2022-01-06
US20220241229A1 (en) 2022-08-04
JP2022536653A (ja) 2022-08-18
EP3980000A1 (en) 2022-04-13
WO2020252005A1 (en) 2020-12-17
CA3142781A1 (en) 2020-12-17
EP3980000A4 (en) 2023-06-21

Similar Documents

Publication Publication Date Title
US12220424B2 (en) Compositions comprising nicotinamide riboside and a urolithin
KR102852384B1 (ko) 노화 방지제 및 노화 방지 방법
US20220241229A1 (en) Methods and Compositions for Altering Senescence Associated Secretory Phenotype
JP2023027149A (ja) 寿命および健康寿命を延ばすための製剤
CN115867289B (zh) 含有nr及/或nmn与芝麻素类的组合物
KR20240057401A (ko) 파라잔틴-기반 카페인 대용 조성물 및 느린 카페인 대사자에서의 이의 사용 방법
US20250082631A1 (en) Sleep improving agent
EP2532351B1 (en) Agent for improving motility function
JP2022504771A (ja) 健康寿命延長を目的とするニコチンアミドリボシド組成物
KR102239075B1 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 근감소증의 예방 또는 치료용 약학 조성물
TW202200129A (zh) 菸鹼醯胺腺嘌呤二核苷酸(nad)濃度上昇劑
JP2024510608A (ja) 眼障害の治療方法及び眼障害の治療のためのマイクロバイオーム組成物、成分、または代謝産物の使用
HK40071633A (en) Methods and compositions for altering senescence associated secretory phenotype
WO2024117173A1 (ja) 痒みの予防又は改善剤
JPWO2008136173A1 (ja) スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤
US20120122984A1 (en) Methods of Treating Lipomas and Liposarcomas
JP6374682B2 (ja) 筋萎縮抑制剤
JP2003511097A (ja) 栄養補助剤
WO2024123738A1 (en) Compositions and methods for treating diseases responsive to akg-vitamin b coadministration
EP4260849A1 (en) Compound for the reduction of white adipose tissue and the treatment of overweight and obesity
JP2024079052A (ja) 痒みの予防又は改善剤
HK40089161A (en) Nicotinamide adenine dinucleotide (nad) concentration increasing agent
CN116847849A (zh) 体温降低剂、体温上升抑制剂、体温降低用食品组合物和体温上升抑制用食品组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40071633

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220301